Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma

Pathology International

Volumn 57, Issue 2, 2007, Pages 53-59

  Sasaki, Eiichi ^a,b   Yatabe, Yasushi ^a   Hashimoto, Mitsuyoshi ^b   Yamashita, Yoriko ^b   Hasegawa, Yuichi ^c   Kojima, Hiroshi ^c   Nagasawa, Toshiro ^c   Mori, Naoyoshi ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cyclin D3; Precursor T cell lymphoblastic lymphoma; T cell development; Thymocytes

Indexed keywords

CD79A ANTIGEN; CYCLIN D3; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHATIC LEUKEMIA; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL; T CELL LYMPHOMA; T LYMPHOCYTE; TUMOR CELL CULTURE;

ANTIGENS, CD79; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; CYCLINS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; LEUKEMIA, T-CELL, ACUTE; LYMPHOMA, LYMPHOBLASTIC; MALE; RECEPTORS, ANTIGEN, T-CELL; THYMUS GLAND;

EID: 33846974070     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2006.02058.x     Document Type: Article

References (37)

1. Sherr CJ. G1 phase progression: Cycling on cue. Cell 1994; 79: 551-5.
2. Pardee AB. G1 events and regulation of cell proliferation. Science 1989; 246: 603-8.
3. Strauss M, Lukas J, Bartek J. Unrestricted cell cycling and cancer. Nat Med 1995; 1: 1245-6.
4. Meyerson M, Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 1994; 14: 2077-86.
5. Bartek J, Bartkova J, Lukas J. The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol 1996; 8: 805-14.
6. Bates S, Bonetta L, MacAllan D et al. CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene 1994; 9: 71-9.
7. Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672-7.
8. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 1996; 68: 67-108.
9. Courjal F, Louason G, Speiser P, Katsaros D, Zeillinger R, Theillet C. Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int J Cancer 1996; 69: 247-53.
10. Shamma A, Doki Y, Shiozaki H et al. Effect of cyclin D1 and associated proteins on proliferation of esophageal squamous cell carcinoma. Int J Oncol 1998; 13: 455-60.
11. Halaban R. Growth factors and melanomas. Semin Oncol 1996; 23: 673-81.
12. Miranda RN, Briggs RC, Kinney MC, Veno PA, Hammer RD, Cousar JB. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia. Mod Pathol 2000; 13: 1308-14.
13. Delmer A, Ajchenbaum-Cymbalista F, Tang R et al. Overexpression of cyclin D2 in chronic B-cell malignancies. Blood 1995; 85: 2870-76.
14. Teramoto N, Pokrovskaja K, Szekely L et al. Expression of cyclin D2 and D3 in lymphoid lesions. Int J Cancer 1999; 81: 543-50.
15. Motokura T, Arnold A. Cyclin D and oncogenesis. Curr Opin Genet Dev 1993; 3: 5-10.
16. Suzuki R, Kuroda H, Komatsu H et al. Selective usage of D-type cyclins in lymphoid malignancies. Leukemia 1999; 13: 1335-42.
17. Nakamura S, Yatabe Y, Seto M. Cyclin D1 overexpression in malignant lymphomas. Pathol Int 1997; 47: 421-9.
18. Yatabe Y, Suzuki R, Tobinai K et al. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: A clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood 2000; 95: 2253-61.
19. Doglioni C, Chiarelli C, Macri E et al. Cyclin D3 expression in normal, reactive and neoplastic tissues. J Pathol 1998; 185: 159-66.
20. Bartkova J, Lukas J, Strauss M, Bartek J. Cyclin D3: Requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene 1998; 17: 1027-37.
21. Sicinska E, Aifantis I, Le Cam L et al. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 2003; 4: 451-61.
22. McLean IW, Nakane PK. Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J Histochem Cytochem 1974; 22: 1077-83.
23. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80.
24. von Boehmer H. Positive selection of lymphocytes. Cell 1994; 76: 219-28.
25. Campana D, Janossy G, Coustan-Smith E et al. The expression of T cell receptor-associated proteins during T cell ontogeny in man. J Immunol 1989; 142: 57-66.
26. Hsu SM, Jaffe ES. Phenotypic expression of T lymphocytes in thymus and peripheral lymphoid tissues. Am J Pathol 1985; 121: 69-78.
27. Gore SD, Kastan MB, Civin CI. Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells. Blood 1991; 77: 1681-90.
28. Barcena A, Muench MO, Galy AH et al. Phenotypic and functional analysis of T-cell precursors in the human fetal liver and thymus: CD7 expression in the early stages of T- and myeloidcell development. Blood 1993; 82: 3401-14.
29. Res P, Blom B, Hori T, Weijer K, Spits H. Downregulation of CD1 marks acquisition of functional maturation of human thymocytes and defines a control point in late stages of human T cell development. J Exp Med 1997; 185: 141-51.
30. Punt JA, Havran W, Abe R, Sarin A, Singer A. T cell receptor (TCR)-induced death of immature CD4+CD8+ thymocytes by two distinct mechanisms differing in their requirement for CD28 costimulation: Implications for negative selection in the thymus. J Exp Med 1997; 186: 1911-22.
31. Nagano M, Kimura N, Akiyoshi T et al. T-stem cell leukemia/lymphoma with both myeloid lineage conversion and T-specific delta recombination. Leuk Res 1997; 21: 763-73.
32. Reinherz EL, Kung PC, Goldstein G, Levey RH, Schlossman SF. Discrete stages of human intrathymic differentiation: Analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci USA 1980; 77: 1588-92.
33. Bernard A, Boumsell L, Reinherz EL et al. Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: Evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood 1981; 57: 1105-10.
34. Foon KA, Todd RF III. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1-31.
35. Roper M, Crist WM, Metzgar R et al. Monoclonal antibody characterization of surface antigens in childhood T-cell lymphoid malignancies. Blood 1983; 61: 830-37.
36. Reth M. The B-cell antigen receptor complex and co-receptors. Immunol Today 1995; 16: 310-13.
37. Hashimoto M, Yamashita Y, Mori N. Immunohistochemical detection of CD79a expression in precursor T cell lymphoblastic lymphoma/leukaemias. J Pathol 2002; 197: 341-7.1